AstraZeneca shares diving as European countries suspend vaccine use

admin
1 Min Read


Vaccines withdrawn by Denmark, Norway and Iceland as “precautions”

Denmark, Norway and Iceland have stopped the Oxford/AstraZeneca vaccine after a Danish woman died from a blood clot after receiving a jab.

The EU Drug Agency said there were no signs that JAB had caused blood clots.

In a statement, Astrazeneca confirmed that the drug had been extensively studied.

“Patient safety is a top priority for AstraZeneca. Regulators have clear and strict efficacy and safety standards for approval of any new drug. Peer-reviewed data is generally well-known. It has been confirmed that it is acceptable, the statement added.

The emerged news came as a setback to pushing vaccinations on the continent, which has gained momentum recently.

– Advertising –

Astrazeneca’s share price fell 2.52% to 7,011p on Thursday.

Share This Article
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *